About HALRIC

Hanseatic Life Science Research Infrastructure Consortium (HALRIC)

During the past decade, significant development and investments have been made in advanced research infrastructures in the Öresund Kattegat Skagerrak (ÖKS)-Hamburg area. The facilities already provide advanced Life Science tools, but there is an untapped potential to further expand the collaboration at and around the sites, as well as cross-borders.

HALRIC started as a 3-year project funded by the EU-program Interreg Öresund-Kattegat-Skagerrak (2023-2026). It aimed to be a springboard for innovation capacity in the ÖKS-Hamburg Life Science sector via increased access to and use of cross-border front-end technologies, instruments, expertise, and data handling solutions.

HALRIC brought companies, hospitals and academic researchers together in collaborations with:

• The large-scale infrastructures, such as MAX IV & DESY and ESS & European XFEL
• And with cutting-edge complementary infrastructures such as cryoEM, advanced biological MS, and 7Tesla-MR.

The infrastructures brought advanced know-how and technology for sample production and preparation. The research facilities were also used in pre-clinical and clinical research areas, bringing the innovation potential close to the patient in the shape of potential new treatments.

Through pilot projects, HALRIC facilitated collaboration between academia, hospitals, SMEs as well as larger biotech and pharma companies. It also worked on prototype models for handling the huge amounts of electronic data generated by such infrastructures, as well as on strengthening the Life Science ecosystems and strategic dialogues between the four countries in the project.

Lund University was lead partner for the project, which included 20 other partner organizations across Sweden, Denmark, Germany and Norway. The consortium constituted the full spectrum of organizations needed for multi-disciplinary collaboration with the Life Science industry.